| Followers | 132 |
| Posts | 6436 |
| Boards Moderated | 0 |
| Alias Born | 10/25/2011 |
Friday, December 29, 2023 10:34:21 AM
$SHMN: MPSTOCK: It's a different ball game now.
Those of us who've hung on... for one reason or another, will reap the benefits.
1. Both Facilities have been verified.
2. I have mutual acquaintances with (Dewey, Aguilar & Bhatt)
It's HIGHLY UNLIKELY, & would be mind boggling if these guys are involved in any scams whatsoever.
3. Barron served his purpose (getting the company to this point via his Wishful thinking & PRs that simply vaporized W/O any verification)
Now all that S/Hs & Stakeholders need are
For the TWO facilities to FIRE on ALL CYLINDERS & Ship product.
And for Aguilar & Bhatt to find an ABBIE Business Partner & ABBIE Sales.
BTW:- FDA Registration assumes that the FDA has done some preliminary inspections & products may ship from those facilities (I know this as someone who's been in Bio-Tech & Med for 20yrs).
However, it's the Company's (facility) responsibility to maintain & show QC data.
This is where Dewey comes in.
Those of us who've hung on... for one reason or another, will reap the benefits.
1. Both Facilities have been verified.
2. I have mutual acquaintances with (Dewey, Aguilar & Bhatt)
It's HIGHLY UNLIKELY, & would be mind boggling if these guys are involved in any scams whatsoever.
3. Barron served his purpose (getting the company to this point via his Wishful thinking & PRs that simply vaporized W/O any verification)
Now all that S/Hs & Stakeholders need are
For the TWO facilities to FIRE on ALL CYLINDERS & Ship product.
And for Aguilar & Bhatt to find an ABBIE Business Partner & ABBIE Sales.
BTW:- FDA Registration assumes that the FDA has done some preliminary inspections & products may ship from those facilities (I know this as someone who's been in Bio-Tech & Med for 20yrs).
However, it's the Company's (facility) responsibility to maintain & show QC data.
This is where Dewey comes in.
Throw me to the WOLVES.......and I shall return LEADING THE PACK!
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
